What is CPT code 0393U for CSF analysis and how to use it?

AI and automation are revolutionizing medical coding and billing. Don't worry, your job isn't going away... yet. But think of all the extra time you'll have to learn new codes! You're going to have to learn to code, which sounds like something a coder should be doing! 😂
Let's talk about a new code that came out for CSF analysis to detect misfolded alpha-synuclein protein. The code is 0393U and it's only used for one test. The SYNTapTM Biomarker Test. I'll explain it all in this article.


What is correct code for Neurology procedure with CSF analysis to detect misfolded alpha-synuclein protein?

Correct modifiers for general anesthesia code explained: 0393U

Medical coding is a vital part of the healthcare system. Medical coders are responsible for translating medical documentation into standardized codes. These codes are used by insurance companies, government agencies, and other healthcare providers to track patient care and determine payment for services. One type of medical code used in medical coding is a CPT (Current Procedural Terminology) code.

CPT codes are a set of codes that describe medical procedures and services. They are developed and maintained by the American Medical Association (AMA). The AMA charges a license fee to use the codes. It is illegal to use CPT codes without a license and the use of outdated CPT codes will lead to coding inaccuracies and can cause significant legal issues. Coders must make sure that they are always using the latest CPT codes as updated and released by AMA. To access updated CPT codes, coders can obtain annual CPT manuals released by the AMA or can access the CPT codes digitally via online subscriptions. It is critical for coders to use only current CPT codes as provided by AMA as failing to do so can result in:

  • Coding inaccuracies resulting in billing errors.
  • Unlawful use of CPT codes leading to legal consequences.
  • Payment issues resulting in under-reimbursement or even denied claims from insurance companies and government agencies.
  • Financial liabilities and penalties from Medicare and Medicaid.

In this article we'll explore one particular code - code 0393U used in neurology to bill for cerebrospinal fluid (CSF) analysis used to detect misfolded alpha-synuclein protein. We'll also look at the use cases of this code, providing a deeper understanding of how medical coders are critical in the field of healthcare.

What is 0393U code used for?

Code 0393U is a proprietary laboratory analyses (PLA) code which is a part of CPT code set used to describe unique laboratory tests conducted by specific manufacturers or labs.

Code 0393U is specifically used for:

  • SYNTapTM Biomarker Test
  • Test is performed by Amprion Clinical Laboratory.
  • The test is a biomarker used for detection of misfolded alpha-synuclein proteins.
  • The test serves as a biomarker for neurodegenerative diseases, particularly Parkinson’s disease (PD) and Lewy body dementia (LBD).

Code 0393U represents a relatively new addition to the CPT code set, coming into effect on July 1st, 2023.

What does code 0393U actually measure?

Imagine a patient named John is concerned about his recent memory problems. He goes to his neurologist, Dr. Smith. During the visit, Dr. Smith considers ordering a CSF test, knowing that it is critical for diagnosis. This is where code 0393U comes into play. Here's how it works:

Dr. Smith discusses with John the need for a CSF test, explaining how it can be instrumental in understanding John's neurological condition. Dr. Smith orders the test, and John undergoes a lumbar puncture procedure. A CSF sample is then collected.

The CSF sample is sent to Amprion Clinical Laboratory, who perform the SYNTapTM Biomarker Test. This is a specialized laboratory test involving a seed amplification assay.

This assay aims to identify the presence of misfolded alpha-synuclein proteins in the CSF specimen. The laboratory analysis involves introducing fluorescently labeled normal alpha-synuclein protein to the sample. The presence of misfolded alpha-synuclein proteins in the CSF can act as seeds for this added protein. These seeds cause the normal alpha-synuclein proteins to misfold and aggregate, leading to an increased fluorescence in the sample.

If the fluorescence signal is detectable, it indicates the presence of misfolded alpha-synuclein protein aggregates. A positive result may serve as a biomarker for Parkinson's disease (PD), Lewy body dementia (LBD), or possibly other conditions.

If John's test result comes back positive, this finding combined with John's clinical presentation and neurological examination findings allows Dr. Smith to diagnose PD or LBD. Dr. Smith discusses the results with John, offering insights into the implications for treatment, management, and overall well-being. John feels reassured that HE has received accurate information about his health and understands the path forward with his treatment.

The accuracy of the results is essential. That's why the AMA assigns specific PLA codes to each laboratory analysis performed. It's important for coders to make sure they choose the right PLA code depending on the specific test conducted.

Is there a better code for analysis of alpha-synuclein proteins in cerebrospinal fluid (CSF)?

One of the challenges medical coders encounter is ensuring that they are using the most appropriate code for a specific medical service or procedure. There are several codes for the analysis of alpha-synuclein proteins in CSF. However, code 0393U holds a unique position in the CPT code set due to its specific purpose. If the SYNTapTM Biomarker Test is performed at Amprion Clinical Laboratory, code 0393U is the only appropriate CPT code. This specificity helps ensure accurate reporting and billing for the particular analysis. The use of another code, instead of code 0393U, could result in incorrect reimbursement or denial of payment.


Use Cases of 0393U code: Applying your knowledge!

Now that you've gained an understanding of the 0393U code, let's explore some use-case scenarios and see how it can be used in different clinical situations:

Case 1: The Early Diagnosis

Maria, a 65-year-old woman, visits her primary care physician, Dr. Jones, due to tremors in her left hand and stiffness in her right arm. After reviewing Maria's medical history and conducting a physical examination, Dr. Jones is concerned about a possible diagnosis of Parkinson’s disease (PD) or a related neurodegenerative disorder. She refers Maria to Dr. Thomas, a neurologist.

Upon the initial examination by Dr. Thomas, Dr. Thomas suggests a CSF analysis as a diagnostic tool to support his initial assessment of PD or LBD. Dr. Thomas discusses this plan with Maria, carefully explaining why this specific test could be a valuable piece of information. He emphasizes that the test is just one part of the overall diagnostic process. Maria expresses understanding and consents to the procedure.

The SYNTapTM Biomarker Test is ordered and performed by Dr. Thomas, who selects CPT code 0393U to capture the specific service provided.

A couple of weeks later, Dr. Thomas reviews the results with Maria. The results indicate a positive result for misfolded alpha-synuclein proteins, providing evidence of possible Parkinson's disease. Dr. Thomas reviews treatment options and discusses ways for Maria to manage her symptoms. He encourages Maria to start engaging with support groups and resources to assist with adjusting to her diagnosis. Maria expresses gratitude for the careful guidance provided and begins actively participating in her treatment and management plan.

Case 2: Differential Diagnosis: A Delicate Case

Imagine a case involving a young patient named Lily, presenting with significant cognitive impairment and memory issues. After multiple tests and evaluations, Lily's neurologist, Dr. Lee, is trying to differentiate between various possibilities. A possibility that requires further investigation is dementia with Lewy bodies (DLB). Dr. Lee, being mind

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.